|
|
|
|
LEADER |
01961nam a22003735i 4500 |
001 |
000291576 |
005 |
20210917131435.0 |
007 |
cr nn 008mamaa |
008 |
151005s2015 ne | s |||| 0|eng d |
020 |
|
|
|a 9789401772006
|
024 |
7 |
|
|a 10.1007/978-94-017-7200-6
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
4 |
|a The Essential Guide to N-of-1 Trials in Health /
|c edited by Jane Nikles, Geoffrey Mitchell.
|
250 |
|
|
|a 1st ed. 2015.
|
260 |
# |
# |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2015.
|
300 |
|
|
|a XI, 245 p. 31 illus., 17 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Preface -- Introduction -- What are N-of-1 trials?- N-of-1 trials in the behavioural sciences -- N-of-1 trials in medical contexts -- Aggregated N-of-1 trials -- Methodological considerations for N-of-1 trials -- Randomization, allocation concealment and blinding -- Data collection and quality control -- Individual reporting of N-of-1 trials to patients and clinicians -- Assessing and reporting adverse events -- Research ethics and N-of-1 trials -- Statistical analysis of N-of-1 trials -- The economics of N-of-1 trials -- Reporting N-of-1 trials to professional audiences -- Single patient open trials -- Systematic review and meta-analysis using N-of-1 trials -- Where are N-of-1 trials headed?- Index.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Pharmacotherapy.
|
650 |
|
0 |
|a Psychology.
|
650 |
|
0 |
|a Statistics .
|
650 |
|
0 |
|a Pharmacy.
|
650 |
1 |
4 |
|a Biomedicine, general.
|
650 |
2 |
4 |
|a Pharmacotherapy.
|
650 |
2 |
4 |
|a Psychology, general.
|
650 |
2 |
4 |
|a Statistics for Life Sciences, Medicine, Health Sciences.
|
650 |
2 |
4 |
|a Pharmacy.
|
700 |
1 |
|
|a Nikles, Jane.
|e editor.
|
700 |
1 |
|
|a Mitchell, Geoffrey.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|